10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2012

Filing Information

Form Type	10-Q
Accession Number	`0001534525-12-000008`
Period End Date	20120229
Filing Date	20120424
Fiscal Year	2012
Fiscal Period	Q2
XBRL Instance	gair-20120229.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 31 Income Statement 28 Cash Flow Statement 20

Balance Sheet 31 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	-	USD	Point-in-time
Cash	`Cash`	$10.00K	USD	Point-in-time
Cash	`Cash`	$11.36K	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	-	USD	Point-in-time
Accounts receivable	`AccountsReceivableGrossCurrent`	$36.04K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$47.39K	USD	Point-in-time
Fixed Assets, net of accumulated depreciation of $8,855 and $0, respectively	`PropertyPlantAndEquipmentNet`	$203.65K	USD	Point-in-time
Fixed Assets, net of accumulated depreciation of $8,855 and $0, respectively	`PropertyPlantAndEquipmentNet`	$212.50K	USD	Point-in-time
Total assets	`Assets`	$222.50K	USD	Point-in-time
Total assets	`Assets`	$251.04K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$7.37K	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$76.80K	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$548.00	USD	Point-in-time
Accrued interest	`InterestPayableCurrent`	$7.10K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$83.89K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.92K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$212.81K	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$212.81K	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding at February 29, 2012 and August 31, 2011, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding at February 29, 2012 and August 31, 2011, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value; 90,000,000 shares authorized, 10,000,000 shares issued and outstanding at February 29, 2012 and August 31, 2011, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Common stock, $0.001 par value; 90,000,000 shares authorized, 10,000,000 shares issued and outstanding at February 29, 2012 and August 31, 2011, respectively	`CommonStockValue`	$10.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	-	USD	Point-in-time
Deficit accumulated during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-8.23K	USD	Point-in-time
Deficit accumulated during development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-55.67K	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$-45.67K	USD	Point-in-time
Total stockholders (deficit) equity	`StockholdersEquity`	$1.76K	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$251.04K	USD	Point-in-time
Total liabilities and stockholders (deficit) equity	`LiabilitiesAndStockholdersEquity`	$222.50K	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	$49.72K	USD	2 Qtrs
Revenue	`Revenues`	$35.97K	USD	1 Quarter
Aircraft maintenance and fee	`EquipmentExpense`	$13.98K	USD	2 Qtrs
Aircraft maintenance and fee	`EquipmentExpense`	$10.45K	USD	1 Quarter
Fuel and oil	`ProductionCosts`	$10.04K	USD	2 Qtrs
Fuel and oil	`ProductionCosts`	$8.62K	USD	1 Quarter
Management fees	`ManagementFees`	$9.07K	USD	2 Qtrs
Management fees	`ManagementFees`	$6.75K	USD	1 Quarter
Professional fees	`ProfessionalFees`	$48.63K	USD	2 Qtrs
Professional fees	`ProfessionalFees`	$30.91K	USD	1 Quarter
Depreciation	`AccumulatedDepreciationDepletionAndAmortizationWritedownOfPropertyPlantAndEquipment`	$5.31K	USD	1 Quarter
Depreciation	`AccumulatedDepreciationDepletionAndAmortizationWritedownOfPropertyPlantAndEquipment`	$8.86K	USD	2 Qtrs
Administrative fees	`AdministrativeFees`	-	USD	1 Quarter
Administrative fees	`AdministrativeFees`	$25.00	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$90.60K	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$62.03K	USD	1 Quarter
Net loss from operations	`OperatingIncomeLoss`	$-26.07K	USD	1 Quarter
Net loss from operations	`OperatingIncomeLoss`	$-40.88K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-6.55K	USD	2 Qtrs
Interest expense	`InterestExpense`	$-3.20K	USD	1 Quarter
Total other income (expense)	`OtherExpenses`	$-3.20K	USD	1 Quarter
Total other income (expense)	`OtherExpenses`	$-6.55K	USD	2 Qtrs
Net loss	`IncomeLossFromContinuingOperations`	$-29.26K	USD	1 Quarter
Net loss	`IncomeLossFromContinuingOperations`	$-47.43K	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	-	USD	2 Qtrs
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.00M	shares	1 Quarter
Weighted average shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	10.00M	shares	2 Qtrs

Cash Flow Statement 20 line items

Line Item	Tag	Value	Unit	Period
Net (loss)	`NetIncomeLoss`	$-47.43K	USD	2 Qtrs
Depreciation	`Depreciation`	$8.86K	USD	2 Qtrs
(Increase)/Decrease in accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-36.04K	USD	2 Qtrs
Increase/(Decrease) in accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$69.42K	USD	2 Qtrs
Increase/(Decrease) in accrued interest	`IncreaseDecreaseInInterestPayableNet`	$6.55K	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.35K	USD	2 Qtrs
Purchase of helicopter	`PaymentsToAcquirePropertyPlantAndEquipment`	$-212.50K	USD	2 Qtrs
Net cash (used) in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-212.50K	USD	2 Qtrs
Proceeds from loan payable	`ProceedsFromNotesPayable`	$212.81K	USD	2 Qtrs
Common stock issued for cash	`ProceedsFromIssuanceOrSaleOfEquity`	$10.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$222.81K	USD	2 Qtrs
Net increase in cash	`CashPeriodIncreaseDecrease`	$1.35K	USD	2 Qtrs
Cash at beginning of period	`Cash`	-	USD	Point-in-time
Cash at beginning of period	`Cash`	$10.00K	USD	Point-in-time
Cash at beginning of period	`Cash`	$11.36K	USD	Point-in-time
Cash at end of period	`Cash`	-	USD	Point-in-time
Cash at end of period	`Cash`	$10.00K	USD	Point-in-time
Cash at end of period	`Cash`	$11.36K	USD	Point-in-time
Cash paid for interest	`InterestPaid`	-	USD	2 Qtrs
Cash paid for taxes	`IncomeTaxesPaid`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.